Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : YOUR FAVORITE INTERNET PICK..... AND WHY ????? -- Ignore unavailable to you. Want to Upgrade?

To: SOROS who wrote (1)	12/17/1998 12:02:00 AM
From: Stock Watcher	Read Replies (1) \| Respond to of 962

S - for $1.15 a share - why not ? Looks like a legit start-up biotech in Phase II trials with some "name" affiliations. How much cash do they have left from IPO ? Any revenue this year ? How long do they have before they'll need more cash ? Announcement looks good; but, they still have a long way to go. Phase III trials are expensive and time-consuming - can they survive until then ? For $1.15 a share - you have my vote for an interesting high-risk situation.